{"DataElement":{"publicId":"5355416","version":"1","preferredName":"Bayer Classification for Corneal Epitheliopathy Grade","preferredDefinition":"Result of assessment for corneal changes using a grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343).","longName":"BAYER_CORN_EPITH_GD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5355414","version":"1","preferredName":"Bayer Classification for Corneal Epitheliopathy Result","preferredDefinition":"A grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343)._The result of an action.","longName":"5355412v1.0:2224045v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"5355412","version":"1","preferredName":"Bayer Classification for Corneal Epitheliopathy","preferredDefinition":"A grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343).","longName":"C128435","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bayer Classification for Corneal Epitheliopathy","conceptCode":"C128435","definition":"A grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"38398293-0635-1D19-E050-BB89AD432BE0","latestVersionIndicator":"Yes","beginDate":"2016-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-22","modifiedBy":"ONEDATA","dateModified":"2016-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224045","version":"1","preferredName":"Outcome","preferredDefinition":"A phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F061C-D115-4EFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"38398293-0643-1D19-E050-BB89AD432BE0","latestVersionIndicator":"Yes","beginDate":"2016-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-22","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5355240","version":"1","preferredName":"Bayer Classification for Corneal Epitheliopathy Grade","preferredDefinition":"A grading system for best corrected visual acuity following treatment with anetumab ravtansine (BAY 94-9343)._A position on a scale of intensity or amount or quality._A grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343)._A position on a scale of intensity or amount or quality.","longName":"BAYER_CORN_EPITH_GD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"7","maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Grade 4","valueDescription":"Bayer Corneal Epitheliopathy Grade 4","ValueMeaning":{"publicId":"5355241","version":"1","preferredName":"Bayer Corneal Epitheliopathy Grade 4","longName":"5355241","preferredDefinition":"Corneal ulcer more severe than grade 3.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bayer Corneal Epitheliopathy Grade 4","conceptCode":"C128444","definition":"Corneal ulcer more severe than grade 3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"382A21AF-ACA0-1D57-E050-BB89AD435D89","latestVersionIndicator":"Yes","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"382A21AF-ACB9-1D57-E050-BB89AD435D89","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"ONEDATA","dateModified":"2016-07-21","deletedIndicator":"No"},{"value":"Grade 3","valueDescription":"Bayer Corneal Epitheliopathy Grade 3","ValueMeaning":{"publicId":"5355242","version":"1","preferredName":"Bayer Corneal Epitheliopathy Grade 3","longName":"5355242","preferredDefinition":"Corneal ulcer without risk of acute rupture; central stromal opacity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bayer Corneal Epitheliopathy Grade 3","conceptCode":"C128443","definition":"Corneal ulcer without risk of acute rupture; central stromal opacity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"382A21AF-ACC5-1D57-E050-BB89AD435D89","latestVersionIndicator":"Yes","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"382A21AF-ACDE-1D57-E050-BB89AD435D89","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"ONEDATA","dateModified":"2016-07-21","deletedIndicator":"No"},{"value":"Grade 1","valueDescription":"Bayer Corneal Epitheliopathy Grade 1","ValueMeaning":{"publicId":"5355243","version":"1","preferredName":"Bayer Corneal Epitheliopathy Grade 1","longName":"5355243","preferredDefinition":"Any stage of superficial punctate keratitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bayer Corneal Epitheliopathy Grade 1","conceptCode":"C128440","definition":"Any stage of superficial punctate keratitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"382A21AF-ACEA-1D57-E050-BB89AD435D89","latestVersionIndicator":"Yes","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"382A21AF-AD03-1D57-E050-BB89AD435D89","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"ONEDATA","dateModified":"2016-07-21","deletedIndicator":"No"},{"value":"Grade 0","valueDescription":"Bayer Corneal Epitheliopathy Grade 0","ValueMeaning":{"publicId":"5355244","version":"1","preferredName":"Bayer Corneal Epitheliopathy Grade 0","longName":"5355244","preferredDefinition":"No pathologic changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bayer Corneal Epitheliopathy Grade 0","conceptCode":"C128437","definition":"No pathologic changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"382A21AF-AD0F-1D57-E050-BB89AD435D89","latestVersionIndicator":"Yes","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"382A21AF-AD28-1D57-E050-BB89AD435D89","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"ONEDATA","dateModified":"2016-07-21","deletedIndicator":"No"},{"value":"Grade 2","valueDescription":"Bayer Corneal Epitheliopathy Grade 2","ValueMeaning":{"publicId":"5355411","version":"1","preferredName":"Bayer Corneal Epitheliopathy Grade 2","longName":"5355411","preferredDefinition":"Epithelial opacities; micro-cysts; micro-deposits; corneal erosion; non-central stromal opacity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bayer Corneal Epitheliopathy Grade 2","conceptCode":"C128442","definition":"Epithelial opacities; micro-cysts; micro-deposits; corneal erosion; non-central stromal opacity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"38398293-0610-1D19-E050-BB89AD432BE0","latestVersionIndicator":"Yes","beginDate":"2016-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"38398293-0629-1D19-E050-BB89AD432BE0","beginDate":"2016-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-22","modifiedBy":"ONEDATA","dateModified":"2016-07-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5355239","version":"1","preferredName":"Bayer Classification for Corneal Epitheliopathy Grade","preferredDefinition":"A grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343).:A position on a scale of intensity or amount or quality.","longName":"C128435:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bayer Classification for Corneal Epitheliopathy","conceptCode":"C128435","definition":"A grading system for changes in corneal morphology following treatment with anetumab ravtansine (BAY 94-9343).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"382A21AF-AC79-1D57-E050-BB89AD435D89","latestVersionIndicator":"Yes","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"ONEDATA","dateModified":"2016-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Application","id":"382A21AF-AC8A-1D57-E050-BB89AD435D89","latestVersionIndicator":"Yes","beginDate":"2016-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-21","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Corneal morphology","type":"Preferred Question Text","description":"Corneal morphology","url":null,"context":"CCR"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"38398293-0675-1D19-E050-BB89AD432BE0","latestVersionIndicator":"Yes","beginDate":"2016-07-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-22","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":"Curated to support NCI CCR clinical trial.7.25.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}